Abstract

The conference will bring together experts in the fields of exposomics, metabolomics, microbiome research, epidemiology, systems biology and bioinformatics from government, industry and academia. Discussions will include the current status and trends in MS characterization of the exposome and the microbiome with the focus on qualitative and quantitative analyses using targeted, semi-targeted and discovery-based/non-targeted methodologies.